Experienced in Nabothian Cyst

Dr. Leslie R. Boyd

Gynecologic Oncology | Obstetrics and Gynecology
New York University
550 1st Ave, 
New York, NY 
Experienced in Nabothian Cyst
New York University
550 1st Ave, 
New York, NY 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Leslie Boyd is a Gynecologic Oncologist and an Obstetrics and Gynecologist in New York, New York. Dr. Boyd is rated as an Experienced provider by MediFind in the treatment of Nabothian Cyst. Her top areas of expertise are Endometrial Cancer, Ovarian Cancer, Ovarian Carcinosarcoma, Oophorectomy, and Hysterectomy.

Her clinical research consists of co-authoring 39 peer reviewed articles and participating in 5 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Gynecologic Oncology
Obstetrics and Gynecology
Licenses
Obstetrics & Gynecology in NY
Hospital Affiliations
Nyu Langone Hospitals
Languages Spoken
English
Gender
Female

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
EmblemHealth
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER COMMERCIAL
  • OTHER MEDICARE PART D
Health First
  • HMO
  • POS
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
View 1 Less Insurance Carrier -

Locations

NEW YORK UNIVERSITY
550 1st Ave, New York, NY 10016
Other Locations
NEW YORK UNIVERSITY
111 Broadway, 2ndf, New York, NY 10006
NEW YORK UNIVERSITY
240 E 38th St, New York, NY 10016

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

5 Clinical Trials

A Randomized, Open-Label, Phase 3 Trial of Tisotumab Vedotin vs Investigator's Choice Chemotherapy in Second- or Third-Line Recurrent or Metastatic Cervical Cancer
A Randomized, Open-Label, Phase 3 Trial of Tisotumab Vedotin vs Investigator's Choice Chemotherapy in Second- or Third-Line Recurrent or Metastatic Cervical Cancer
Enrollment Status: Active_not_recruiting
Publish Date: September 15, 2025
Intervention Type: Drug
Study Drugs: Tisotumab Vedotin, Topotecan, Vinorelbine, Gemcitabine, Irinotecan, Pemetrexed
Study Phase: Phase 3
A Randomized Phase III Trial of Radiation Therapy and Cisplatin Alone or in Combination With Intravenous Triapine in Women With Newly Diagnosed Bulky Stage IB2, Stage II, IIIB, or IVA Cancer of the Uterine Cervix or Stage II-IVA Vaginal Cancer
A Randomized Phase III Trial of Radiation Therapy and Cisplatin Alone or in Combination With Intravenous Triapine in Women With Newly Diagnosed Bulky Stage IB2, Stage II, IIIB, or IVA Cancer of the Uterine Cervix or Stage II-IVA Vaginal Cancer
Enrollment Status: Active_not_recruiting
Publish Date: August 05, 2025
Intervention Type: Radiation, Drug, Other
Study Drugs: Cisplatin, Triapine
Study Phase: Phase 3
A Two-arm, Randomized, Non-comparative, Phase 2 Trial of AGEN2034 (Anti-PD-1) as a Monotherapy or Combination Therapy With AGEN1884 (Anti- CTLA4) or With Placebo in Women With Recurrent Cervical Cancer (Second Line) - RaPiDS
A Two-arm, Randomized, Non-comparative, Phase 2 Trial of AGEN2034 (Anti-PD-1) as a Monotherapy or Combination Therapy With AGEN1884 (Anti- CTLA4) or With Placebo in Women With Recurrent Cervical Cancer (Second Line) - RaPiDS
Enrollment Status: Active_not_recruiting
Publish Date: February 20, 2025
Intervention Type: Drug
Study Drugs: AGEN-2034 PD-1 Antibody, AGEN-1884 CTLA4 Antibody
Study Phase: Phase 2
A Prospective, Randomized, Double-Blind, Placebo-Controlled Phase 3 Study of VGX-3100 Delivered Intramuscularly Followed by Electroporation With CELLECTRA™-5PSP for the Treatment of HPV-16 and/or HPV-18 Related High Grade Squamous Intraepithelial Lesion (HSIL) of the Cervix
A Prospective, Randomized, Double-Blind, Placebo-Controlled Phase 3 Study of VGX-3100 Delivered Intramuscularly Followed by Electroporation With CELLECTRA™-5PSP for the Treatment of HPV-16 and/or HPV-18 Related High Grade Squamous Intraepithelial Lesion (HSIL) of the Cervix
Enrollment Status: Completed
Publish Date: July 27, 2023
Intervention Type: Biological, Device
Study Drug: VGX-3100
Study Phase: Phase 3
Identification of Circulating Tumor Cells in Patients With HPV 16 or 18 Associated Cervical Cancer
Identification of Circulating Tumor Cells in Patients With HPV 16 or 18 Associated Cervical Cancer
Enrollment Status: Completed
Publish Date: August 05, 2022
Intervention Type: Diagnostic test
View 4 Less Clinical Trials

39 Total Publications

What are we worth? An SGO analysis of compensation structures that measure and value work in academic gynecologic oncology practices.
What are we worth? An SGO analysis of compensation structures that measure and value work in academic gynecologic oncology practices.
Journal: Gynecologic oncology
Published: April 10, 2025
Similar Doctors
Advanced in Nabothian Cyst
Dr. Konstantin Zakashansky
Gynecologic Oncology | Obstetrics and Gynecology | Oncology
Advanced in Nabothian Cyst
Dr. Konstantin Zakashansky
Gynecologic Oncology | Obstetrics and Gynecology | Oncology

Icahn School Of Medicine At Mount Sinai

1000 10th Ave, 
New York, NY 
 (2.0 miles away)
212-523-4000
Languages Spoken:
English
See accepted insurances

Konstantin Zakashansky is a Gynecologic Oncologist and an Obstetrics and Gynecologist in New York, New York. Dr. Zakashansky is rated as a Distinguished provider by MediFind in the treatment of Nabothian Cyst. His top areas of expertise are Endometrial Cancer, Ovarian Carcinosarcoma, Endometrial Polyps, Oophorectomy, and Hysterectomy.

Advanced in Nabothian Cyst
Dr. Valentin G. Kolev
Gynecologic Oncology | Obstetrics and Gynecology
Advanced in Nabothian Cyst
Dr. Valentin G. Kolev
Gynecologic Oncology | Obstetrics and Gynecology

Icahn School Of Medicine At Mount Sinai

1 Gustave Levy Place, Mount Sinai Hospital, 
New York, NY 
 (3.4 miles away)
212-241-2232
Languages Spoken:
English
See accepted insurances

Valentin Kolev is a Gynecologic Oncologist and an Obstetrics and Gynecologist in New York, New York. Dr. Kolev is rated as a Distinguished provider by MediFind in the treatment of Nabothian Cyst. His top areas of expertise are Endometrial Cancer, Cervical Cancer, Neuroendocrine Carcinoma of the Cervix, Hysterectomy, and Oophorectomy.

Advanced in Nabothian Cyst
Dr. Monica P. Hayes
Gynecologic Oncology | Oncology | Obstetrics and Gynecology
Advanced in Nabothian Cyst
Dr. Monica P. Hayes
Gynecologic Oncology | Oncology | Obstetrics and Gynecology

Icahn School Of Medicine At Mount Sinai

1 Gustave Levy Place, 
New York, NY 
 (3.4 miles away)
212-241-2232
Languages Spoken:
English
See accepted insurances

Monica Hayes is a Gynecologic Oncologist and an Oncologist in New York, New York. Dr. Hayes is rated as a Distinguished provider by MediFind in the treatment of Nabothian Cyst. Her top areas of expertise are Ovarian Cancer, Endometrial Cancer, Sertoli-Leydig Cell Tumor, Hysterectomy, and Hernia Surgery.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Boyd's expertise for a condition
ConditionClose
    View All 11 Advanced Conditions
    View All 22 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile